IGFBP3 and obesity due to melanocortin 4 receptor deficiency: observed an association of overweight with overall survival only in breast cancer patients with IGFBP2-positive tumors and found that IGFBP3 was correlated with BMI.21 It is possible that women with preexisting obesity are more likely to express IGFBP2.